Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Current pharmacological treatment approaches for alcohol dependence.

Müller CA, Geisel O, Banas R, Heinz A.

Expert Opin Pharmacother. 2014 Mar;15(4):471-81. doi: 10.1517/14656566.2014.876008. Epub 2014 Jan 23. Review.

PMID:
24456374
2.

Pharmacotherapy of alcoholism - an update on approved and off-label medications.

Soyka M, Müller CA.

Expert Opin Pharmacother. 2017 Aug;18(12):1187-1199. doi: 10.1080/14656566.2017.1349098. Epub 2017 Jul 24. Review.

PMID:
28658981
3.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2002;(2):CD001867. Review. Update in: Cochrane Database Syst Rev. 2005;(1):CD001867.

PMID:
12076425
4.

Recent Developments in Pharmacotherapy of Alcoholism.

Soyka M, Lieb M.

Pharmacopsychiatry. 2015 Jul;48(4-5):123-35. doi: 10.1055/s-0035-1547237. Epub 2015 Mar 11. Review.

PMID:
25761458
5.

Pharmacotherapy for alcohol dependence: status of current treatments.

Franck J, Jayaram-Lindström N.

Curr Opin Neurobiol. 2013 Aug;23(4):692-9. doi: 10.1016/j.conb.2013.05.005. Epub 2013 Jun 26. Review.

PMID:
23810221
6.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2000;(3):CD001867. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD001867.

PMID:
10908513
7.

A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.

Simpson TL, Malte CA, Dietel B, Tell D, Pocock I, Lyons R, Varon D, Raskind M, Saxon AJ.

Alcohol Clin Exp Res. 2015 May;39(5):808-17. doi: 10.1111/acer.12703. Epub 2015 Apr 1.

8.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001867. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD001867.

PMID:
15674887
9.

Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.

Palpacuer C, Duprez R, Huneau A, Locher C, Boussageon R, Laviolle B, Naudet F.

Addiction. 2018 Feb;113(2):220-237. doi: 10.1111/add.13974. Epub 2017 Sep 20. Review.

PMID:
28940866
10.

Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial.

Petrakis IL, Desai N, Gueorguieva R, Arias A, O'Brien E, Jane JS, Sevarino K, Southwick S, Ralevski E.

Alcohol Clin Exp Res. 2016 Jan;40(1):178-86. doi: 10.1111/acer.12926. Epub 2015 Dec 19.

PMID:
26683790
11.

Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.

Mann K, Bladström A, Torup L, Gual A, van den Brink W.

Biol Psychiatry. 2013 Apr 15;73(8):706-13. doi: 10.1016/j.biopsych.2012.10.020. Epub 2012 Dec 11.

PMID:
23237314
12.

Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential.

Soyka M.

Expert Opin Pharmacother. 2016;17(4):619-26. doi: 10.1517/14656566.2016.1146689. Epub 2016 Feb 16. Review.

PMID:
26810044
13.

[The pharmacologic treatment of the alcohol dependence].

Castro LA, Baltieri DA.

Rev Bras Psiquiatr. 2004 May;26 Suppl 1:S43-6. Epub 2005 Jan 4. Portuguese.

14.

Nalmefene. Alcohol dependence: no advance.

[No authors listed]

Prescrire Int. 2014 Jun;23(150):150-2.

PMID:
25121147
15.

Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder.

Petrakis IL, Poling J, Levinson C, Nich C, Carroll K, Ralevski E, Rounsaville B.

Biol Psychiatry. 2006 Oct 1;60(7):777-83.

PMID:
17008146
16.

Acamprosate for the treatment of alcohol dependence.

Boothby LA, Doering PL.

Clin Ther. 2005 Jun;27(6):695-714. Review.

PMID:
16117977
17.

Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

Johnson BA.

Biochem Pharmacol. 2008 Jan 1;75(1):34-56. Epub 2007 Aug 9. Review.

18.

Opioid antagonists for alcohol dependence.

Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD001867. doi: 10.1002/14651858.CD001867.pub2. Review.

PMID:
21154349
19.

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.

Gual A, He Y, Torup L, van den Brink W, Mann K; ESENSE 2 Study Group.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1432-42. doi: 10.1016/j.euroneuro.2013.02.006. Epub 2013 Apr 3.

PMID:
23562264
20.

New pharmacological approaches for the treatment of alcoholism.

Soyka M, Roesner S.

Expert Opin Pharmacother. 2006 Dec;7(17):2341-53. Review.

PMID:
17109610

Supplemental Content

Support Center